1. Kesharwani DK, Mohammad Sh, Acharya N, Joshi KS. Fertility with early reduction of ovarian reserve. Cureus 2022; 14: e30326. [
DOI:10.7759/cureus.30326]
2. Yun BH, Kim G, Park SH, Noe EB, Seo SK, Cho S, et al. In vitro fertilization outcome in women with diminished ovarian reserve. Obstet Gynecol Sci 2017; 60: 46-52. [
DOI:10.5468/ogs.2017.60.1.46] [
PMID] [
PMCID]
3. Jirge PR. Poor ovarian reserve. J Hum Reprod Sci 2016; 9: 63-69. [
DOI:10.4103/0974-1208.183514] [
PMID] [
PMCID]
4. Grisendi V, La Marca A. Individualization of controlled ovarian stimulation in vitro fertilization using ovarian reserve markers. Minerva Ginecol 2017; 69: 250-258. [
DOI:10.23736/S0026-4784.17.04044-8] [
PMID]
5. Alles J, Fehlmann T, Fischer U, Backes C, Galata V, Minet M, et al. An estimate of the total number of true human miRNAs. Nucleic Acids Res 2019; 47: 3353-3364. [
DOI:10.1093/nar/gkz097] [
PMID] [
PMCID]
6. Abu-Halima M, Ayesh BM, Hart M, Alles J, Fischer U, Hammadeh M, et al. Differential expression of miR-23a/b-3p and its target genes in male patients with subfertility. Fertil Steril 2019; 112: 323-335. [
DOI:10.1016/j.fertnstert.2019.03.025] [
PMID]
7. Abu‐Halima M, Belkacemi A, Ayesh BM, Simone Becker L, Sindiani AM, Fischer U, et al. MicroRNA‐targeting in spermatogenesis: Over‐expressions of microRNA‐23a/b‐3p and its affected targeting of the genes ODF2 and UBQLN3 in spermatozoa of patients with oligoasthenozoospermia. Andrology 2021; 9: 1137-1144. [
DOI:10.1111/andr.13004] [
PMID]
8. Abu‐Halima M, Galata V, Backes C, Keller A, Hammadeh M, Meese E. MicroRNA signature in spermatozoa and seminal plasma of proven fertile men and in testicular tissue of men with obstructive azoospermia. Andrologia 2020; 52: e13503. [
DOI:10.1111/and.13503] [
PMID]
9. Abu-Halima M, Ludwig N, Hart M, Leidinger P, Backes C, Keller A, et al. Altered micro-ribonucleic acid expression profiles of extracellular microvesicles in the seminal plasma of patients with oligoasthenozoospermia. Fertil Steril 2016; 106: 1061-1069. [
DOI:10.1016/j.fertnstert.2016.06.030] [
PMID]
10. Salas-Huetos A, James ER, Aston KI, Jenkins TG, Carrell DT, Yeste M. The expression of miRNAs in human ovaries, oocytes, extracellular vesicles, and early embryos: A systematic review. Cells 2019; 8: 1564. [
DOI:10.3390/cells8121564] [
PMID] [
PMCID]
11. Noveski P, Popovska‐Jankovic K, Kubelka‐Sabit K, Filipovski V, Lazarevski S, Plaseski T, et al. Micro RNA expression profiles in testicular biopsies of patients with impaired spermatogenesis. Andrology 2016; 4: 1020-1027. [
DOI:10.1111/andr.12246] [
PMID]
12. Khawar MB, Mehmood R, Roohi N. MicroRNAs: Recent insights towards their role in male infertility and reproductive cancers. Bosn J Basic Med Sci 2019; 19: 31-42. [
DOI:10.17305/bjbms.2018.3477] [
PMID] [
PMCID]
13. Abu-Halima M, Khaizaran ZA, Ayesh BM, Fischer U, Khaizaran SA, Al-Battah F, et al. MicroRNAs in combined spent culture media and sperm are associated with embryo quality and pregnancy outcome. Fertil Steril 2020; 113: 970-980. [
DOI:10.1016/j.fertnstert.2019.12.028] [
PMID]
14. Salilew-Wondim D, Gebremedhn S, Hoelker M, Tholen E, Hailay T, Tesfaye D. The role of micrornas in mammalian fertility: From gametogenesis to embryo implantation. Int J Mol Sci 2020; 21: 585. [
DOI:10.3390/ijms21020585] [
PMID] [
PMCID]
15. Abu-Halima M, Häusler S, Backes C, Fehlmann T, Staib C, Nestel S, et al. Micro-ribonucleic acids and extracellular vesicles repertoire in the spent culture media is altered in women undergoing in vitro fertilization. Sci Rep 2017; 7: 13525. [
DOI:10.1038/s41598-017-13683-8] [
PMID] [
PMCID]
16. Lee S-Y, Kang Y-J, Kwon J, Nishi Y, Yanase T, Lee K-A, et al. miR-4463 regulates aromatase expression and activity for 17β-estradiol synthesis in response to follicle-stimulating hormone. Clin Exp Reprod Med 2020; 47: 194-206. [
DOI:10.5653/cerm.2019.03412] [
PMID] [
PMCID]
17. Turathum B, Gao E-M, Chian R-C. The function of cumulus cells in oocyte growth and maturation and in subsequent ovulation and fertilization. Cells 2021; 10: 2292. [
DOI:10.3390/cells10092292] [
PMID] [
PMCID]
18. Du X, Li Q, Yang L, Liu L, Cao Q, Li Q. SMAD4 activates Wnt signaling pathway to inhibit granulosa cell apoptosis. Cell Death Dis 2020; 11: 373. [
DOI:10.1038/s41419-020-2578-x] [
PMID] [
PMCID]
19. de Conceicao arros-Oliveira M, Costa-Silva DR, Dos Santos AR, Pereira RO, Soares-Junior JM, da Silva BB. Influence of CYP19A1 gene expression levels in women with breast cancer: A systematic review of the literature. Clinics 2021; 76: e2846. [
DOI:10.6061/clinics/2021/e2846] [
PMID] [
PMCID]
20. Hashemain Z, Amiri-Yekta A, Khosravifar M, Alvandian F, Shahhosseini M, Hosseinkhani S, et al. CYP19A1 promoters activity in human granulosa cells: A comparison between PCOS and normal subjects. Cell J 2022; 24: 170-175.
21. Hong L, Peng S, Li Y, Fang Y, Wang Q, Klausen C, et al. miR-106a increases granulosa cell viability and is downregulated in women with diminished ovarian reserve. J Clin Endocrinol Metab 2018; 103: 2157-2166. [
DOI:10.1210/jc.2017-02344] [
PMID]
22. Tian X, Fei Q, Du M, Zhu H, Ye J, Qian L, et al. miR‐130a‐3p regulated TGF‐β1‐induced epithelial‐mesenchymal transition depends on SMAD4 in EC‐1 cells. Cancer Med 2019; 8: 1197-1208. [
DOI:10.1002/cam4.1981] [
PMID] [
PMCID]
23. Xie S, Batnasan E, Zhang Q, Li Y. MicroRNA expression is altered in granulosa cells of ovarian hyperresponders. Reprod Sci 2016; 23: 1001-1010. [
DOI:10.1177/1933719115625849] [
PMID]
24. Xie J, Xu X, Liu S. Intercellular communication in the cumulus-oocyte complex during folliculogenesis: A review. Front Cell Dev Biol 2023; 11: 1087612. [
DOI:10.3389/fcell.2023.1087612] [
PMID] [
PMCID]
25. Zhang C, Song S, Yang M, Yan L, Qiao J. Diminished ovarian reserve causes adverse ART outcomes attributed to effects on oxygen metabolism function in cumulus cells. BMC Genomics 2023; 24: 655. [
DOI:10.1186/s12864-023-09728-0] [
PMID] [
PMCID]
26. May-Panloup P, Ferré-L'Hôtellier V, Morinière C, Marcaillou C, Lemerle S, Malinge M-C, et al. Molecular characterization of corona radiata cells from patients with diminished ovarian reserve using microarray and microfluidic-based gene expression profiling. Hum Reprod 2012; 27: 829-843. [
DOI:10.1093/humrep/der431] [
PMID]
27. Lu G, Wong MS, Xiong MZQ, Leung CK, Su XW, Zhou JY, et al. Circulating micro RNA s in delayed cerebral infarction after aneurysmal subarachnoid hemorrhage. J Am Heart Assoc 2017; 6: e005363. [
DOI:10.1161/JAHA.116.005363] [
PMID] [
PMCID]
28. He X-M, Zheng Y-Q, Liu S-Z, Liu Y, He Y-Z, Zhou X-Y. Altered plasma microRNAs as novel biomarkers for arteriosclerosis obliterans. J Atheroscler Thromb 2016; 23: 196-206. [
DOI:10.5551/jat.30775] [
PMID]
29. Wang X, He X, Deng X, He Y, Zhou X. Roles of miR‑4463 in H2O2‑induced oxidative stress in human umbilical vein endothelial cells. Mol Med Rep 2017; 16: 3242-3252. [
DOI:10.3892/mmr.2017.7001] [
PMID] [
PMCID]
30. He X, Du C, Zou Y, Long Y, Huang C, Chen F, et al. Downregulation of microRNA-4463 attenuates high-glucose-and hypoxia-induced endothelial cell injury by targeting PNUTS. Cell Physiol Biochem 2018; 49: 2073-2087. [
DOI:10.1159/000493717] [
PMID]
31. Wang X, Du C, He X, Deng X, He Y, Zhou X. MiR-4463 inhibits the migration of human aortic smooth muscle cells by AMOT. Biosci Rep 2018; 38: BSR20180150. [
DOI:10.1042/BSR20180150] [
PMID] [
PMCID]
32. Ding C-F, Chen W-Q, Zhu Y-T, Bo Y-L, Hu H-M, Zheng R-H. Circulating microRNAs in patients with polycystic ovary syndrome. Hum Fertil 2015; 18: 22-29. [
DOI:10.3109/14647273.2014.956811] [
PMID]